Navidea Biopharmaceutical... (NAVB)
0.00
null (null%)
At close: Jan 16, 2025, 8:00 PM
0.00
900.00%
Pre-market Sep 03, 2024, 09:30 AM EDT
Price Reaction to Earnings Reports
This table provides an overview of how a stock's price historically reacted around earnings reports. It displays key metrics like price changes over specific timeframes and Relative Strength Index (RSI).
| Report Date | -3 Days | -2 Days | -1 Day | Open | High | Low | Close | +1 Day | +2 Days | +3 Days | +1 Week | -1 Week | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar 24, 2021
(Q4) AMC Q4 2020 | 2.28 | 2.20 | 2.06 | 2.17 | 2.17 | 1.93 | 2.08 | 2.08 | 1.99 | 2.00 | 2.15 | 2.25 | ||
IV: - RSI: 38 NAVB % | -1.3% | -3.51% | -3.51% | 5.34%
| 5.34%
| -6.31%
| 0.97%
| 0.00% | -4.33% | 0.50% | 6.44% | -0.44% | ||
Nov 12, 2020
(Q3) AMC Q3 2020 | 2.21 | 2.25 | 2.24 | 2.78 | 3.15 | 2.40 | 2.76 | 2.70 | 2.59 | 2.44 | 2.36 | 2.32 | ||
IV: - RSI: 34 NAVB % | -3.91% | 1.81% | 1.81% | 24.11%
| 40.62%
| 7.14%
| 23.21%
| -2.17% | -4.07% | -5.79% | 3.96% | -0.43% | ||
| Daily change and RSI 14 are based on the report date for BMO releases and the following day for AMC releases. | ||||||||||||||
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options Data
- Instant access to live options data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.